Patheon

PTI-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about PTI-T

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
January 26, 2005
(A Top Pick Nov 16/04. Up 14%.) Thinks it will go to at least the top of the trading range of $16. The times are right for the group.
Patheon (PTI-T)
January 26, 2005
(A Top Pick Nov 16/04. Up 14%.) Thinks it will go to at least the top of the trading range of $16. The times are right for the group.
Bill Carrigan
Technical Analyst, Getting Technical Info Service
Price
$10.120
Owned
Yes
SELL
SELL
January 26, 2005
Would sell into this strength. An extremely tough business. It's characterized by rapid turnover of products, capital intensive and very fleeting profitability. Fully valued. Legal issues with management that has to be worked through.
Patheon (PTI-T)
January 26, 2005
Would sell into this strength. An extremely tough business. It's characterized by rapid turnover of products, capital intensive and very fleeting profitability. Fully valued. Legal issues with management that has to be worked through.
Danny Tomka
Portfolio Manager, MFC Global Investment Management
Price
$10.120
Owned
No
BUY
BUY
January 17, 2005
Believes in the long term management. Just made an acquisition in Puerto Rico which will be good.
Patheon (PTI-T)
January 17, 2005
Believes in the long term management. Just made an acquisition in Puerto Rico which will be good.
David Baskin
President, Baskin Wealth Management
Price
$10.080
Owned
Yes
TOP PICK
TOP PICK
January 14, 2005
What will be emerging over the next decade is more health care and cheaper. Attractive price. A good consevative way to participate in a growth sector.
Patheon (PTI-T)
January 14, 2005
What will be emerging over the next decade is more health care and cheaper. Attractive price. A good consevative way to participate in a growth sector.
Fred Sturm
Chief Investment Strategist, Mackenzie Financial (Resource and Precious Metals)
Price
$9.910
Owned
Yes
DON'T BUY
DON'T BUY
January 12, 2005
Year-end selling took place and there is a rally coming out of year end. Doesn't meet his tests.
Patheon (PTI-T)
January 12, 2005
Year-end selling took place and there is a rally coming out of year end. Doesn't meet his tests.
David Burrows
President & Chief Investment Strategist, Barometer Capital Management
Price
$10.010
Owned
No
TOP PICK
TOP PICK
January 6, 2005
Trading at a very cheap multiple at about 14 X versus its historical multiple of 20 X earnings. The last 3 quarters have started to see the earnings ramp up. Margins are better too. Also likes their Peurto Rico acquisition which can be very accretive to them.
Patheon (PTI-T)
January 6, 2005
Trading at a very cheap multiple at about 14 X versus its historical multiple of 20 X earnings. The last 3 quarters have started to see the earnings ramp up. Margins are better too. Also likes their Peurto Rico acquisition which can be very accretive to them.
Werner Muehelemann
Vice President and Senior Portfolio Manager, ING Funds
Price
$8.510
Owned
Yes
DON'T BUY
DON'T BUY
November 29, 2004
Has had a lot of promise, but has never come through. Has made a lot of acquisitions and taken on a lot of debt. Earnings have not come through the way they should have.
Patheon (PTI-T)
November 29, 2004
Has had a lot of promise, but has never come through. Has made a lot of acquisitions and taken on a lot of debt. Earnings have not come through the way they should have.
Norman Levine
Managing Director, Portfolio Management Corp
Price
$9.000
Owned
No
TOP PICK
TOP PICK
November 26, 2004
(A Top Pick Sept 14/04. Up 4%.) Has been into long term support this fall. Likes the sector.
Patheon (PTI-T)
November 26, 2004
(A Top Pick Sept 14/04. Up 4%.) Has been into long term support this fall. Likes the sector.
Bill Carrigan
Technical Analyst, Getting Technical Info Service
Price
$8.970
Owned
Yes
TOP PICK
TOP PICK
November 26, 2004
Feels that pharmaceutical companies are under a lot of pressure and have to become more efficient in manufacturing and increasing outsourcing. Likes the acquisition. Very profitable plants. Will generate surplus cash.
Patheon (PTI-T)
November 26, 2004
Feels that pharmaceutical companies are under a lot of pressure and have to become more efficient in manufacturing and increasing outsourcing. Likes the acquisition. Very profitable plants. Will generate surplus cash.
Jonathen Wellum, B. Comm, B. Sc
Chief Executive Officer, AIC Limited
Price
$8.970
Owned
No
HOLD
HOLD
November 22, 2004
Seems like they have one bad situation after another. Now have an issue with the OSC. Still believes the story. Very good management. Very cheap.
Patheon (PTI-T)
November 22, 2004
Seems like they have one bad situation after another. Now have an issue with the OSC. Still believes the story. Very good management. Very cheap.
David Baskin
President, Baskin Wealth Management
Price
$7.650
Owned
Yes
DON'T BUY
DON'T BUY
November 18, 2004
Once confusion starts, it never seems to go away, especially in this unforgiving market.
Patheon (PTI-T)
November 18, 2004
Once confusion starts, it never seems to go away, especially in this unforgiving market.
Bill Carrigan
Technical Analyst, Getting Technical Info Service
Price
$7.710
Owned
No
SELL
SELL
November 9, 2004
OSC is conducting a probe re insider trading. Really haven't delivered on their promises. A very difficult business. Capital intensive.
Patheon (PTI-T)
November 9, 2004
OSC is conducting a probe re insider trading. Really haven't delivered on their promises. A very difficult business. Capital intensive.
Danny Tomka
Portfolio Manager, MFC Global Investment Management
Price
$8.600
Owned
No
WAIT
WAIT
October 26, 2004
Feels the bottom will be about $8.20 as long as there is no other cockroaches. Could drop further with tax loss selling in Nov/Dec.
Patheon (PTI-T)
October 26, 2004
Feels the bottom will be about $8.20 as long as there is no other cockroaches. Could drop further with tax loss selling in Nov/Dec.
Brian Acker, CA
Chief Executive Officer, President and Chief Inves, Acker Finley Inc.
Price
$8.520
Owned
Unknown
BUY
BUY
October 21, 2004
One of the better manufacturers of drugs. Had a stumble this last year as a drug being manufactured in the UK reached the end of its product cycle. Has positive earnings. Not a low PE. Prospects are quite good.
Patheon (PTI-T)
October 21, 2004
One of the better manufacturers of drugs. Had a stumble this last year as a drug being manufactured in the UK reached the end of its product cycle. Has positive earnings. Not a low PE. Prospects are quite good.
Michael Sprung
President, Sprung Investment Management
Price
$8.900
Owned
Yes
BUY
BUY
September 28, 2004
Well managed company. Has had some problems with a plant in the UK, but this is getting cleared up. Profitable.
Patheon (PTI-T)
September 28, 2004
Well managed company. Has had some problems with a plant in the UK, but this is getting cleared up. Profitable.
Michael Sprung
President, Sprung Investment Management
Price
$9.130
Owned
Yes
Showing 46 to 60 of 194 entries